Femasys (FEMY) Net Equity Issued and Repurchased (2020 - 2025)
Femasys (FEMY) posted Net Equity Issued and Repurchased of $3.5 million for Q4 2025, up 495.55% on a QoQ basis from -$882026.0 in Q2 2025.
Femasys (FEMY) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Femasys' Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $3.5 million for Q4 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.0 million (up 1.28% YoY) and the FY2025 annual result came in at $8.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was $3.5 million for Q4 2025 at Femasys, up from -$882026.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $31.7 million in Q2 2021 and bottomed at -$882026.0 in Q2 2025.
- A 5-year average of $5.0 million and a median of $59583.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased tumbled 85.25% — and 2024, when it surged 257830.63%.
- Femasys' Net Equity Issued and Repurchased stood at $14401.0 in 2021, then surged by 313.74% to $59583.0 in 2022, then soared by 12758.86% to $7.7 million in 2023, then tumbled by 110.47% to -$802242.0 in 2024, then soared by 534.88% to $3.5 million in 2025.
- Business Quant data shows FEMY's Net Equity Issued and Repurchased at $3.5 million in Q4 2025, -$882026.0 in Q2 2025, and $5.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 7.43 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.72 Mn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.49 Mn |
| Dec 31, 2025 | 3.49 Mn |
| Jun 30, 2025 | -882,026.00 |
| Jun 30, 2025 | -882,026.00 |
| Mar 31, 2025 | 5.39 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Jun 30, 2024 | -802,242.00 |
| Jun 30, 2024 | -802,242.00 |
| Mar 31, 2024 | 8.70 Mn |
| Mar 31, 2024 | 8.70 Mn |
| Dec 31, 2023 | 7.66 Mn |
| Dec 31, 2023 | 7.66 Mn |
| Mar 31, 2023 | 3,373.00 |
| Mar 31, 2023 | 3,373.00 |
| Dec 31, 2022 | 59,583.00 |
| Dec 31, 2022 | 59,583.00 |
| Dec 31, 2021 | 14,401.00 |
| Dec 31, 2021 | 14,401.00 |
| Jun 30, 2021 | 31.72 Mn |
| Jun 30, 2021 | 31.72 Mn |